Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter P Jeske

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 10, 2009
Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic productsCafer Adiguzel, Walter P Jeske, Debra Hoppensteadt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Development of a Synthetic Heparin Pentasaccharide: FondaparinuxJeanine M Walenga, Jawed Fareed, Walter P Jeske, et al.
Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 20, 2012
Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimenMichael Ashbrook, Jeanine M Walenga, Jeffrey Schwartz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 20, 2013
Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopeniaJeanine M Walenga, Margaret Prechel, Debra Hoppensteadt, et al.
Expert Opinion on Investigational Drugs|February 28, 2002
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentJeanine M Walenga, Walter P Jeske, M Michel Samama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass graftingBrian R Untch, Walter P Jeske, Jeffrey Schwartz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 24, 2020
Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist DevicesJeanine M Walenga, Tania A Torres, Walter P Jeske, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 10, 2009
Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic productsCafer Adiguzel, Walter P Jeske, Debra Hoppensteadt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Development of a Synthetic Heparin Pentasaccharide: FondaparinuxJeanine M Walenga, Jawed Fareed, Walter P Jeske, et al.
Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 20, 2012
Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimenMichael Ashbrook, Jeanine M Walenga, Jeffrey Schwartz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 20, 2013
Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopeniaJeanine M Walenga, Margaret Prechel, Debra Hoppensteadt, et al.
Expert Opinion on Investigational Drugs|February 28, 2002
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentJeanine M Walenga, Walter P Jeske, M Michel Samama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 28, 2007
Inflammatory and hemostatic activation in patients undergoing off-pump coronary artery bypass graftingBrian R Untch, Walter P Jeske, Jeffrey Schwartz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 24, 2020
Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist DevicesJeanine M Walenga, Tania A Torres, Walter P Jeske, et al.
Pageof 5